HomeATAI • NASDAQ
add
ATAI Life Sciences NV
Previous close
$1.52
Day range
$1.42 - $1.71
Year range
$1.02 - $2.85
Market cap
270.16M USD
Avg Volume
1.74M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 40.00K | -54.02% |
Operating expense | 22.64M | -15.89% |
Net income | -26.29M | -159.41% |
Net profit margin | -65.72K | -229.22% |
Earnings per share | -0.16 | -164.00% |
EBITDA | -22.52M | 15.84% |
Effective tax rate | 0.67% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 85.92M | -58.89% |
Total assets | 197.52M | -35.92% |
Total liabilities | 51.20M | 28.95% |
Total equity | 146.32M | — |
Shares outstanding | 160.62M | — |
Price to book | 1.67 | — |
Return on assets | -27.34% | — |
Return on capital | -31.34% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -26.29M | -159.41% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2018
Website
Employees
83